Company / Named in our posts
Tvardi Therapeutics, Inc..
Follow Tvardi Therapeutics, Inc.Clinical-stage biopharmaceutical company focused on developing novel oral small-molecule therapies targeting STAT3 to treat fibrosis-driven diseases.[1]
01Deal
Deals on Carrywatch
Every deal that names Tvardi Therapeutics, Inc., and its role in each.
Cara Therapeutics, Inc. / Tvardi Therapeutics, Inc.
Cara Therapeutics and Tvardi Therapeutics complete merger
See deal detailsDeal Web
Tvardi Therapeutics, Inc. and 1 firm it shares a posted deal with, and the path to any other firm.
Financials
6 fiscal years of figures as Tvardi Therapeutics, Inc. reported them.
News
Loading headlines.
Sources
As of 25 Oct 2026.
- 01Tvardi Therapeutics, Inc. Form 8-K
U.S. Securities and Exchange Commission · Researched 25 Oct 2026
Deal posts naming Tvardi Therapeutics, Inc.:
- P01